TY - JOUR
T1 - Pediatric transplantation in Europe during the COVID-19 pandemic
T2 - Early impact on activity and healthcare
AU - Doná, Daniele
AU - Torres Canizales, Juan
AU - Benetti, Elisa
AU - Cananzi, Mara
AU - De Corti, Federica
AU - Calore, Elisabetta
AU - Hierro, Loreto
AU - Ramos Boluda, Esther
AU - Melgosa Hijosa, Marta
AU - Garcia Guereta, Luis
AU - Pérez Martínez, Antonio
AU - Barrios, Maribel
AU - Costa Reis, Patricia
AU - Teixeira, Ana
AU - Lopes, Maria Francelina
AU - Kaliciński, Piotr
AU - Branchereau, Sophie
AU - Boyer, Olivia
AU - Debray, Dominque
AU - Sciveres, Marco
AU - Wennberg, Lars
AU - Fischler, Björn
AU - Barany, Peter
AU - Baker, Alastair
AU - Baumann, Ulrich
AU - Schwerk, Nicolaus
AU - Nicastro, Emanuele
AU - Candusso, Manila
AU - Toporski, Jacek
AU - Sokal, Etienne
AU - Stephenne, Xavier
AU - Lindemans, Caroline
AU - Miglinas, Marius
AU - Rascon, Jelena
AU - Jara, Paloma
PY - 2020/10
Y1 - 2020/10
N2 - The current pandemic SARS-CoV-2 has required an unusual allocation of resources that can negatively impact chronically ill patients and high-complexity procedures. Across the European Reference Network on Pediatric Transplantation (ERN TransplantChild), we conducted a survey to investigate the impact of the COVID-19 outbreak on pediatric transplant activity and healthcare practices in both solid organ transplantation (SOT) and hematopoietic stem cell transplantation (HSCT). The replies of 30 professionals from 18 centers in Europe were collected. Twelve of 18 centers (67%) showed a reduction in their usual transplant activity. Additionally, outpatient visits have been modified and restricted to selected ones, and the use of telemedicine tools has increased. Additionally, a total of 14 COVID-19 pediatric transplanted patients were identified at the time of the survey, including eight transplant recipients and six candidates for transplantation. Only two moderate-severe cases were reported, both in HSCT setting. These survey results demonstrate the limitations in healthcare resources for pediatric transplantation patients during early stages of this pandemic. COVID-19 disease is a major worldwide challenge for the field of pediatric transplantation, where there will be a need for systematic data collection, encouraging regular discussions to address the long-term consequences for pediatric transplantation candidates, recipients, and their families.
AB - The current pandemic SARS-CoV-2 has required an unusual allocation of resources that can negatively impact chronically ill patients and high-complexity procedures. Across the European Reference Network on Pediatric Transplantation (ERN TransplantChild), we conducted a survey to investigate the impact of the COVID-19 outbreak on pediatric transplant activity and healthcare practices in both solid organ transplantation (SOT) and hematopoietic stem cell transplantation (HSCT). The replies of 30 professionals from 18 centers in Europe were collected. Twelve of 18 centers (67%) showed a reduction in their usual transplant activity. Additionally, outpatient visits have been modified and restricted to selected ones, and the use of telemedicine tools has increased. Additionally, a total of 14 COVID-19 pediatric transplanted patients were identified at the time of the survey, including eight transplant recipients and six candidates for transplantation. Only two moderate-severe cases were reported, both in HSCT setting. These survey results demonstrate the limitations in healthcare resources for pediatric transplantation patients during early stages of this pandemic. COVID-19 disease is a major worldwide challenge for the field of pediatric transplantation, where there will be a need for systematic data collection, encouraging regular discussions to address the long-term consequences for pediatric transplantation candidates, recipients, and their families.
KW - adolescents
KW - children
KW - coronavirus disease 2019
KW - COVID-19
KW - hematopoietic stem cell transplantation
KW - pediatric transplantation
KW - post-transplant management
KW - SARS-CoV-2
KW - solid organ transplantation
KW - young
U2 - 10.1111/ctr.14063
DO - 10.1111/ctr.14063
M3 - Article
C2 - 32786120
AN - SCOPUS:85091288163
SN - 0902-0063
VL - 34
JO - Clinical Transplantation
JF - Clinical Transplantation
IS - 10
M1 - e14063
ER -